A Phase 2, Randomized, Parallel Group, Multi-Center, Multi-National Study for the Evaluation of Safety and Efficacy of Two Fixed Dosages of DU-176b in Subjects With Non-Valvular Atrial Fibrillation.
Phase of Trial: Phase II
Latest Information Update: 30 Jan 2015
At a glance
- Drugs Edoxaban; Warfarin
- Indications Stroke; Thromboembolism
- Focus Adverse reactions
- Sponsors Daiichi Sankyo Inc
- 13 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Feb 2010 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 13 Dec 2008 New trial record.